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Membrane-disruptive actionIn this study, we isolated (-)-olivil-9′-O-β-D-glucopyranoside (OLI9G), a phytochemical from the stem bark of
Sambucus williamsii, and investigated the antifungal mechanism of OLI9G against Candida albicans. First of all,
the antifungal susceptibility testing and hemolysis assay showed that OLI9G exerted a potent activity without
hemolysis compared to the activity of amphotericin B. To investigate the mechanism of action of OLI9G, we
ﬁrst examined membrane depolarization using cyanine dye, 3,3′-dipropylthiacarbocyanine iodide (diSC35).
The results showed that OLI9G signiﬁcantly changed the fungal membrane potential. To further understand
this activity on the membrane, we did the propidium iodide (PI) inﬂux assay. From the results, OLI9G caused
membrane permeabilization in the fungal membrane, and the three dimensional (3D) ﬂow cytometric con-
tour plot from the PI inﬂux assay further showed that the cells had shrunk due to the membrane damage.
Finally, the membrane-active mechanism of OLI9G was conﬁrmed by synthesizing a model membrane,
calcein-encapsulating large unilamellar vesicles (LUVs). The calcein leakage showed the membrane-
disruptive effects caused by direct action of OLI9G. In conclusion, the current study suggests that OLI9G exerts
its antifungal activity through a membrane-disruptive action.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Fungal infection is one of the major threats to humans. Healthy
humans are sensitive to superﬁcial, cutaneous, subcutaneous and sys-
temic infections inducing various conditions, ranging frommild disease
to life-threatening disease. Concretely, many infections are caused by
opportunistic pathogens: (a) endogenous (infections caused by Candida
species) or (b) acquired from the environment (infections caused by
Cryptococcus species and Aspergillus species) [1,2].
Candida albicans is one of the most common fungal pathogens and a
major cause of high morbidity and mortality in immune-compromised
patients [3–5]. Candida species form bioﬁlms on not only host tissues
but also on medical devices and implants in the patients [6]. However,
due to the side effects from the toxicity of drugs and the emergence of
resistant strains, antifungal drugs for the treatment of systemic and in-
vasive candidiasis are limited to polyenes, allylamines, azoles and
echinocandin classes of molecules [7–9].
We have focused on ﬁnding novel antifungal compounds from var-
ious sources, for treating diseases caused by C. albicans or other fungal
strains. Phytochemical, isolated from plants, has been regarded as anti-
microbial agents [10]. The herb Sambucus williamsii is a folk medicinal
plant used for its therapeutic properties. The genus Sambucus, widely+82 53 955 5522.
l rights reserved.distributed in Europe, Asia andNorth Africa, has beenused in traditional
medicine as an analgesic, antivirus, antiinﬂammatory, homoeostatic,
and diuretic drugs which act on bruises, fractures, and edema [11]. In
this study, we investigated the antifungal effect of a phytochemical,
(-)-olivil-9′-O-β-D-glucopyranoside (OLI9G), isolated from the stem
bark of S. williamsii.
2. Materials and methods
2.1. Extraction and isolation
The air-dried stem bark of S. williamsii (840 g) was cut and
extracted with MeOH at 80 °C for 4 h. The MeOH extract (57.10 g)
was suspended in water and then partitioned sequentially with
equal volumes of dichloromethane (CH2Cl2), ethyl acetate (EtOAc),
and n-butanol (n-BuOH). The EtOAc fraction (4.2 g) was subjected
to column chromatography over a HP-20 by eluting it with MeOH:
H2O (5:95 → 25:75 → 40:60 → 100:0) gradient system. Based on
their TLC pattern, the fractions were combined to yield subfractions,
which were designated E1–E4. The subfraction, E2 (2.47 g) was then pu-
riﬁed by column chromatography over a HP-20 MeOH:H2O (0:100→
5:95→ 15:85→ 30:70→ 100:0) gradient system to afford four sub-
fractions (E2-1–E2-4). The subfraction E2-2 was followed with repeated
column chromatography (Silica gel, CHCl3:MeOH:H2O, 4:4:1:0.1→
1:1:0.1) to give (-)-olivil-9′-O-β-D-glucopyranoside (15.3 mg). The
physico-chemical data including 1H NMR, 13C NMR, and HSQC of
Fig. 1. Chemical structure of OLI9G isolated from Sambucus williamsii.
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in the literature [12,13]. Amorphous powder, mp: 169–172 °C;
[α]D25: −26.8°(c 0.23, MeOH); UV λmax (MeOH) nm: 209, 225, 279;
IR vmax (KBr) cm−1: 3420, 1605, 1515, 1458, 1271, 1227, 1073;
ESI-MS m/z: 537 [M − H]− ;1H NMR (500 MHz, CD3OD) δ:7.11(1H,
d, J = 1.5 Hz, H-2), 6.91(1H, br s, H-2′), 6.89(1H, dd, J = 1.5
6.5 Hz, H-6), 6.75(1H, d, J = 6.5 Hz, H-5), 6.72(2H, m, H-5′/H-6′),
4.73(1H, d, J = 7.0 Hz, H-7′), 4.30(1H, d, J = 6.5 Hz, Glc-H-1″),
3.85(3H, s, C-3′-OCH3), 3.84(3H, s, C-3-OCH3), 3.05(1H, d, J =
11.5 Hz, H-7α), 2.91(1H, d, J = 12.0 Hz, H-7β), 2.46(1H, dd, J =
6.0, 11.0 Hz, H-8′);13C NMR (125 MHz, CD3OD) δ: 149.13(C-3),
148.66(C-3′), 147.42(C-4), 146.24(C-4′), 134.92(C-1), 130.49(C-1′),
124.17(C-6), 120.91(C-6′), 115.93(C-5), 115.90(C-5′), 115.52(C-2),
111.66(C-2′), 85.37(C-7′), 82.51(C-8), 77.76(C-9), 68.47(C-9′),
60.37(C-8′), 56.55(C-3′-OCH3), 56.53(C-3-OCH3), 40.83(C-7),
104.96(Glc, C-1″), 78.16(Glc, C-3″/C-5″), 75.32(Glc, C-2″), 71.78(Glc,
C-4″), 62.87(Glc, C-6″).
2.2. Fungal strains and antifungal susceptibility testing
Malassezia furfur (KCTC 7744) and Trichosporon beigelii (KCTC 7707)
were obtained from the Korean Collection for Type Cultures (KCTC;
Daejeon, Korea). C. albicans (ATCC 90028) and Candida parapsilosis
(ATCC 22019) were obtained from the American Type Culture Collec-
tion (ATCC; Manassas, VA, USA). Fungal cells were cultured in YPD
broth (Difco) containing yeast extract, peptone, and dextrose (50 g/l)
with aeration at 28 °C. M. furfur was cultured at 32 °C in YM broth
(Difco) containing yeast extract, malt extract, peptone, dextrose
(21 g/l), and 1% olive oil. Fungal cells (2 × 104 cells/ml) were inoculat-
ed into the broth, and 0.1 ml/well of the mixture was dispensed into
microtiter plates. Theminimum inhibitory concentration (MIC)was de-
termined with a serial twofold dilution of the compounds following a
microdilution method and the MTT (3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide) assay [14,15]. After 48 h of in-
cubation, the minimal compound concentration that prevented the
growth of a given test organism was determined and was deﬁned
as the MIC. The growth was assayed with a microtiter ELISA reader
(Molecular Devices Emax) by monitoring the absorption at 580 nm.
The MIC values were determined by three independent assays.
2.3. Hemolytic activity assay
The hemolytic activity of the compounds was evaluated by measur-
ing the absorbance at 414 nmwith an ELISA reader to determine the re-
lease of hemoglobin from a 4% suspension of human erythrocytes [14].
The hemolysis percentage was calculated using the following equation:
%hemolysis = 100 × [(A414 nm in the compound solution − A414 nm in
PBS) / (A414 nm in 0.1% Triton X-100 − A414 nm in PBS)], where A is the
absorbance.
2.4. Membrane depolarization assay
Measurements of cytoplasmic membrane depolarization were
made using a membrane potential-sensitive probe, diSC35, purchased
from Sigma Chemical Co. (USA). C. albicans (2 × 104/ml) were cul-
tured aerobically at 35 °C for 24 h in RPMI 1640 (165 mM MOPS,
pH 7.0, with L-glutamine and NaHCO3). The cells were washed with
Ca2+ and Mg2+ free PBS. Changes in ﬂuorescence due to the collapse
of the cytoplasmic membrane potential were continuously monitored
at 20 °C using a Shimadzu RF-5301 spectroﬂuorophotometer at an
excitation wavelength of 622 nm and an emission wavelength of
670 nm. When the dye uptake was maximal, as indicated by a stable
reduction in ﬂuorescence due to the quenching of the accumulated
dye in the membrane interior, compounds (at the MIC) were added
to the cell. Measurements were repeated two times under each con-
dition to ensure reproducibility [16].2.5. Propidium iodide (PI) inﬂux analysis and three dimensional (3D)
ﬂow cytometric contour plot
C. albicans cells (2 × 104 cells/ml) were treated with the com-
pounds (at the MIC) and incubated for 2 h at 30 °C. After incubation,
the cells were harvested and suspended in PBS. Subsequently, the
cells were treated with 10 μM of PI and incubated for 30 min at
4 °C. Flow cytometric analysis was performed by using a FACSCalibur
ﬂow cytometer (Becton Dickinson, USA) [17].2.6. Calcein leakage from liposomes
Calcein-encapsulating large unilamellar vesicles (LUVs) composed
of phosphatidylcholine/phosphatidylethanolamine/phosphatidylinositol/
ergosterol (5:4:1:2, w/w/w/w) were prepared by vortexing the dried
lipids in dye buffer solution (70 mM calcein, 10 mM Tris, 150 mM NaCl,
and 0.1 mM EDTA, pH 7.4). The suspension was freeze-thawed in liquid
nitrogen over 11 cycles and extruded through polycarbonate ﬁlters
(two stacked200 nmpore-sizeﬁlters) by a LiposoFast extruder (Avestin).
Untrapped calcein was removed with a gel ﬁltration process on a
Sephadex G50 column. The release of calcein was monitored by measur-
ing the ﬂuorescence intensity at λex 490 nm and λem 520 nm using an
RF-5301PC spectroﬂuorophotometer (Shimadzu). The measurements
were done at 25 °C. Twenty microliters of 10% Triton X-100 was added
to vesicles to determine 100% dye leakage. The dye-leakage percentage
was calculated as follows: %dye leakage = 100 × (F − F0) / (Ft − F0),
where F represents the ﬂuorescence intensity 2 min after the addition
of the compounds, and F0 and Ft represent the ﬂuorescence intensity
without the compounds and with Triton X-100, respectively [14].3. Results and discussion
3.1. Puriﬁcation and structure analysis of OLI9G
We isolated the OLI9G from the ethyl acetate soluble fraction of
the MeOH extract of S.williamsii by repeated silica gel, and HP-20 col-
umn chromatography. The chemical structure of this compound was
determined as OLI9G by comparing their spectroscopic data (1H, 13C
NMR, 1H–1H COSY, HSQC, HMBC) with those reported in the litera-
ture (Fig. 1) [12,13].
Table 1
The antifungal activity of OLI9G and amphotericin B.
Fungal strains MIC (μg/ml)
OLI9G Amphotericin B
C. albicans ATCC90028 6.0 3.0
C. parapsilosis ATCC22019 1.5 1.5
T. beigelii KCTC7707 3.0 1.5–3.0
M. furfur KCTC7744 6.0 3.0
Fig. 2. Effects of the compounds on the membrane potential of intact C. albicans. DiSC35
ﬂuorescence was measured as described in Materials and methods. The compounds
were treated at the MIC value.
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In the current study, we isolated phytochemical, OLI9G, and inves-
tigated the antifungal activity and its mode of action. First of all, we
examined the antifungal activity of OLI9G against pathogenic fungal
strains, such as C. albicans, C. parapsilosis, M. furfur and T. beigelii.
Amphotericin B, a polyene antifungal compound, was used as a posi-
tive control. The result showed that OLI9G had antifungal activity, with
aMIC value in the range of 1.5–6.0 μg/ml (Table 1). Amphotericin B had
amore potent activitywith, aMIC value in the range of 1.5–3.0 μg/ml. In
the hemolytic assay (Table 2), OLI9G did not show any hemolysis
against human erythrocytes, whereas amphotericin B showed high he-
molysis as reported in a literature [18]. These results suggest that OLI9G
has potential as a novel antifungal agent for treating fungal diseases in
humans, without cytotoxicity.
3.3. The effect of OLI9G on the fungal membrane
Previously, various extracts from plant species have been tested
against bacterial or fungal strains in vitro, and some of them have
shown a signiﬁcant antimicrobial activity. All these ﬁndings have pro-
vided some indications for the potential to be applied in combination
with conventional antibiotics to control infectious diseases. Unfortu-
nately, most data acquired have been only preliminary and derived
from in vitro studies, potentiation assays and efﬂux studies and the
mechanisms of action are often not fully understood [19].
Therefore, to further investigate the mechanism of action of OLI9G
for exerting its antifungal activity, we ﬁrst performed membrane
studies since many phytochemicals are known to exert their activity
on the microbial plasma membrane [20,21]. We used 2 dyes, diSC35
and PI. DiSC35 is a membrane potential-sensitive ﬂuorescent probe
[22]. If it crosses the outer membrane, diSC35 will be taken up by
the cells, according to the magnitude of the electrical potential gradi-
ent of the cytoplasmic membrane. Thereafter, it accumulates in the
membrane, where it self-quenches its own ﬂuorescence. Providing
that the compounds disrupt the cytoplasmic membrane and that
this disruption results in the depolarization of the electrical potential
gradient, we can check the release of the dye by measuring an in-
crease in ﬂuorescence [23]. PI intercalates between the bases of
DNA, with little or no sequence preference and with a stoichiometry
of one dye molecule per four to ﬁve base pairs of DNA [24]. It
can enter the membrane-compromised cells, after which its ﬂuores-
cence is enhanced 20–30 folds due to the binding [25]. Furthermore,
with the PI inﬂux assay, we gained 3D ﬂow cytometric contour-plot
data, demonstrated with FS (y-axis) and SS (90° scattering, SS log,Table 2
Hemolytic activity of OLI9G and amphotericin B against human erythrocytes.
Compounds Hemolysis (%)
48.0 μg/ml 24.0 μg/ml 12.
OLI9G 0 0 0
Amphotericin B 87.8 73.0 39.x-axis). FS is an indicator regarding size and SS is an indicator regard-
ing granularity. The z-axis represents the intensity of the cellular pop-
ulation [17].
The results showed that the treatment of OLI9G and amphotericin
B increased the diSC35 ﬂuorescence intensity in C. albicans (Fig. 2).
This result indicates that not only amphotericin B but also OLI9G de-
polarizes the fungal membrane potential. Furthermore, in the PI stain-
ing assay, OLI9G induced the inﬂux of PI (41.9%), and amphotericin B
showed an inﬂux of 57.1% (Fig. 3A–C). In the 3D ﬂow cytometric
contour-plot data, the cells treated with OLI9G showed a decreased FS
value, like the action of amphotericin B (Fig. 3D–F). It means that
OLI9G made the size of the cells smaller compared with the non-
treated cells. Taken together, OLI9G induced depolarization and perme-
abilization in the fungal cell membrane, and ﬁnally the cells shrank to
large degree.3.4. Membrane-disruptive action of OLI9G
To conﬁrm the membrane-active mechanism of OLI9G, we in-
vestigated the leakage of calcein dye from LUVs, mimicking the
outer leaﬂet of the plasma membrane of C. albicans. The composi-
tion of the LUVs was phosphatidylcholine/phosphatidylethanolamine/
phosphatidylinositol/ergosterol (5:4:1:2, w/w/w/w) [26]. Liposome
is a vesicle-like structure, consisted of phospholipids organized as
concentrical bilayers containing an aqueous compartment in the inside
[27]. Due to their amphipathic characteristics, they can merge sub-
stances with the aqueous compartment, the lipidic bilayer, or distribut-
ed in both compartments [28]. Liposome is also employed as a useful
tool for mimicking the biological membrane environments [29]. The re-
sults showed that the positive control, amphotericin B, caused calcein
leakage from the LUVs within 2 min and that OLI9G also caused weaker
but signiﬁcant level of leakage, compared to the leakage caused by
amphotericin B (Fig. 4). The calcein leakage from the LUVs conﬁrmed0 μg/ml 6.0 μg/ml 3.0 μg/ml 1.5 μg/ml
0 0 0
2 27.7 11.4 5.7
Fig. 3. (A–C) Flow cytometric analysis of membrane permeabilization detected by a PI inﬂux assay in C. albicans. (A) Control. (B) Cells treated with amphotericin B. (C) Cells treated
with OLI9G. (D–F) Three-dimensional (3D)-ﬂow cytometric contour-plot analysis of C. albicans treated with the compounds. FS (y-axis) and SS (90° scattering, x-axis) are an in-
dicator of size and granularity, respectively. The z-axis represents the cellular population intensity. (D) Control. (E) Cells treated with amphotericin B. (F) Cells treated with
OLI9G.
2005H. Choi et al. / Biochimica et Biophysica Acta 1828 (2013) 2002–2006that OLI9G had membrane-disruptive action caused by direct action
rather than indirect action on membrane proteins. Therefore, mem-
brane disruption by OLI9G induced a breakdown of the transmembranal
potential and ion gradients. These actions eventually led to cell shrink-
age and fungal cell death.
S. williamsii contain many phytochemicals, (+)-pinoresinol [30],
lariciresinol [20], and (+)-medioresinol [31], possessing antimicrobi-
al effects against human pathogenic microorganisms. As noted, in this
study, we isolated a phytochemical from S. williamsii, OLI9G, and
demonstrated the antifungal activity and mechanism of action of
OLI9G. The results suggest that OLI9G has antifungal effects with a
membrane-disruptive action. Finally, this compound could be used
in the development of new antifungal therapeutic agents.Fig. 4. Calcein leakage from phosphatidylcholine/phosphatidylethanolamine/phos-
phatidylinositol/ergosterol (5:4:1:2, w/w/w/w) LUVs induced by the compounds
(6.0, 12.0, 24.0 and 48.0 μg/ml). The error bars represent the SD values for three inde-
pendent experiments, performed in triplicate.Acknowledgements
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